Lucy joined the Centre for Process Innovation (CPI) in September 2013 as Lead Biopharmaceutical Engineer and was part of the team responsible for the design and build of the organisation’s Darlington-based National Biologics Manufacturing Centre.
Prior to her arrival, Lucy was a lecturer in Biopharmaceutical Engineering in the Department of Chemical Engineering and Advanced Materials at Newcastle University, and had also been a Research Fellow in Newcastle University Business School.
A founding member of the ATMP Manufacturing Community, Lucy has a Masters Degree in Biochemical Engineering with Bioprocess Management from University College London, and an Engineering Doctorate in Biochemical Engineering and Bioprocess Leadership from University College London.
CPI, which is part of the Government’s High Value Manufacturing Catapult, works with partners to help bridge the gap between innovation and commercialisation.
Offering open-access, state-of-the-art facilities across the North-East of England, CPI supports SMEs, academia and large corporate organisations working in diverse markets, such as pharmaceuticals, speciality chemicals, food and drink, electronics and transport, to develop, prove and prototype inventions into next generation products and processes.
Its combination of innovation processes and outstanding scientific and technical expertise enables partners to take more products to market faster and at a lower cost.
The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.